English

NeurogesX Inc

EDGAR

Quarterly report (10-Q) · filed 2012-11-14

28 filing records in this dataset, filed from 2007-06-13 to 2012-11-14. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

583 thousand USD

2012 Q3 · USD

Exact inputs and evidence

Revenue: 583000 USD Source

Operating margin

-229.85%

2012 Q3 · %

Exact inputs and evidence

Operating Income: -1340000 USD Source
Revenue: 583000 USD Source

Operating cash flow

-3.64 million USD

2012 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -18985000 USD Source
Operating Cash Flow: -15341000 USD Source

Free cash flow

-3.69 million USD

2012 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -18985000 USD Source
Operating Cash Flow: -15341000 USD Source
Capital Expenditure: 73000 USD Source
Capital Expenditure: 26000 USD Source

Cash and cash equivalents: 7.96 million USD 2012-09-30 Source
Exact value

7955000 USD
Long-term debt including current maturities: 73.1 million USD 2012-09-30 Source
Exact value

73124000 USD
Shares outstanding: 33.3 million shares 2012-09-30 Source
Exact value

33329119 shares

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2012-11-14.

Financial data available through: 2011-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2011-12-31
Operating income: 3 of 11 periods available· newest 2011-12-31
Net income: 3 of 11 periods available· newest 2011-12-31
Operating cash flow: 3 of 11 periods available· newest 2011-12-31
Capital expenditure: 3 of 11 periods available· newest 2011-12-31
Total assets: Multiple units; comparison withheld· newest 2011-12-31
liabilities: No compatible figures in this window
Current assets: Multiple units; comparison withheld· newest 2011-12-31
Current liabilities: Multiple units; comparison withheld· newest 2011-12-31
Cash and cash equivalents: Multiple units; comparison withheld· newest 2011-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2011-12-31
Shares outstanding: Multiple units; comparison withheld· newest 2011-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+281.5%

Prior period

Unit12 688,000

2010-01-01 – 2010-12-31
Current period

Unit12 2.63 million

2011-01-01 – 2011-12-31

Exact inputs and evidence

2625000 − 688000 = 1937000 Unit12

688000 Unit12 · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
2625000 Unit12 · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · NeurogesX Inc · 2011-12-31 NeurogesX Inc (edgar:1385830) Year-over-year change in Revenue: 1937000 Unit12 Concept: fundies:Revenue Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T19:55:01Z Snapshot: ae364e0c8dcadb5fc06f95a6b6dfdb69f3e4fa2afa8144eee986a6ffeb2adc4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385830?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 2625000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385830/000119312512137708/ngsx-20111231.xml#301796 Filing: 000119312512137708 Input fundies:Revenue: 688000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385830/000119312512137708/ngsx-20111231.xml#301660 Filing: 000119312512137708
The citation records this snapshot. The page link may show a newer release later.
Net income
−Unit12 5.03 million

Prior period

−Unit12 44.52 million

2010-01-01 – 2010-12-31
Current period

−Unit12 49.55 million

2011-01-01 – 2011-12-31

Exact inputs and evidence

-49545000 − -44516000 = -5029000 Unit12

-44516000 Unit12 · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
-49545000 Unit12 · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · NeurogesX Inc · 2011-12-31 NeurogesX Inc (edgar:1385830) Year-over-year change in Net income: -5029000 Unit12 Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T19:55:01Z Snapshot: ae364e0c8dcadb5fc06f95a6b6dfdb69f3e4fa2afa8144eee986a6ffeb2adc4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385830?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -49545000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385830/000119312512137708/ngsx-20111231.xml#233330 Filing: 000119312512137708 Input fundies:NetIncome: -44516000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385830/000119312512137708/ngsx-20111231.xml#232991 Filing: 000119312512137708
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−Unit12 2.69 million

Prior period

−Unit12 42.42 million

2010-01-01 – 2010-12-31
Current period

−Unit12 45.11 million

2011-01-01 – 2011-12-31

Exact inputs and evidence

-45108000 − -42417000 = -2691000 Unit12

-42417000 Unit12 · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
-45108000 Unit12 · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · NeurogesX Inc · 2011-12-31 NeurogesX Inc (edgar:1385830) Year-over-year change in Operating cash flow: -2691000 Unit12 Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T19:55:01Z Snapshot: ae364e0c8dcadb5fc06f95a6b6dfdb69f3e4fa2afa8144eee986a6ffeb2adc4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385830?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -45108000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385830/000119312512137708/ngsx-20111231.xml#232459 Filing: 000119312512137708 Input fundies:OperatingCashFlow: -42417000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385830/000119312512137708/ngsx-20111231.xml#232266 Filing: 000119312512137708
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-72.5%

Prior period

Unit12 415,000

2010-01-01 – 2010-12-31
Current period

Unit12 114,000

2011-01-01 – 2011-12-31

Exact inputs and evidence

114000 − 415000 = -301000 Unit12

415000 Unit12 · 2010-01-01 – 2010-12-31
Inspect prior input Prior source
114000 Unit12 · 2011-01-01 – 2011-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · NeurogesX Inc · 2011-12-31 NeurogesX Inc (edgar:1385830) Year-over-year change in Capital expenditure: -301000 Unit12 Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T19:55:01Z Snapshot: ae364e0c8dcadb5fc06f95a6b6dfdb69f3e4fa2afa8144eee986a6ffeb2adc4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385830?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 114000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385830/000119312512137708/ngsx-20111231.xml#252829 Filing: 000119312512137708 Input fundies:CapitalExpenditure: 415000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385830/000119312512137708/ngsx-20111231.xml#252639 Filing: 000119312512137708
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2011 2011-01-01 – 2011-12-31

Revenue Unit12 2.63 million 100% of revenue
Operating costs Derived Unit12 41.78 million 1,592% of revenue
Operating income −Unit12 39.16 million −1,492% of revenue
Tax, interest and other Derived Unit12 10.39 million 396% of revenue
Net income −Unit12 49.55 million −1,887% of revenue

Cash

Operating cash flow −Unit12 45.11 million −1,718% of revenue
Capital expenditure Unit12 114,000 4.3% of revenue
Free cash flow Derived −Unit12 45.22 million −1,723% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2009 Operating loss: operating costs were 1,179% of revenue.
2010 Operating loss: operating costs were 5,886% of revenue.
2011 Operating loss: operating costs were 1,592% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2009 2009-01-01 – 2009-12-31	2006000	23655000 Derived	-21649000	218000 Derived	-21867000	28731000 Derived	Source 2009-01-01 – 2009-12-31: 2006000 Unit12 Inspect Revenue Open source 2009-01-01 – 2009-12-31: -21649000 Unit12 Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -21867000 Unit12 Inspect Net Income Open source 2009-01-01 – 2009-12-31: 29187000 Unit12 Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 456000 Unit12 Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	688000	40497000 Derived	-39809000	4707000 Derived	-44516000	-42832000 Derived	Source 2010-01-01 – 2010-12-31: 688000 Unit12 Inspect Revenue Open source 2010-01-01 – 2010-12-31: -39809000 Unit12 Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -44516000 Unit12 Inspect Net Income Open source 2010-01-01 – 2010-12-31: -42417000 Unit12 Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 415000 Unit12 Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	2625000	41781000 Derived	-39156000	10389000 Derived	-49545000	-45222000 Derived	Source 2011-01-01 – 2011-12-31: 2625000 Unit12 Inspect Revenue Open source 2011-01-01 – 2011-12-31: -39156000 Unit12 Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -49545000 Unit12 Inspect Net Income Open source 2011-01-01 – 2011-12-31: -45108000 Unit12 Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 114000 Unit12 Inspect Capital Expenditure Open source

Amounts are exact, in Unit12.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit12 2.6M 2011

Values and sources

Revenue values and source evidence
Period	Series	Value(Unit12)	Source evidence
20092009-12-31	Revenue	2006000	Revenue: 2006000 Open source
20102010-12-31	Revenue	688000	Revenue: 688000 Open source
20112011-12-31	Revenue	2625000	Revenue: 2625000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

281.5% 2011

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Year over year	No prior comparable period	Revenue: 2006000 Open source
20102010-12-31	Year over year	-65.7%	Revenue: 688000 Open source Revenue: 2006000 Open source
20112011-12-31	Year over year	281.5%	Revenue: 2625000 Open source Revenue: 688000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -1,491.7% 2011

Net margin -1,887.4% 2011

Free cash flow margin -1,722.7% 2011

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20092009-12-31	Operating margin	-1,079.2%	Operating Income: -21649000 Open source Revenue: 2006000 Open source
20102010-12-31	Operating margin	-5,786.2%	Operating Income: -39809000 Open source Revenue: 688000 Open source
20112011-12-31	Operating margin	-1,491.7%	Operating Income: -39156000 Open source Revenue: 2625000 Open source
20092009-12-31	Net margin	-1,090.1%	Net Income: -21867000 Open source Revenue: 2006000 Open source
20102010-12-31	Net margin	-6,470.3%	Net Income: -44516000 Open source Revenue: 688000 Open source
20112011-12-31	Net margin	-1,887.4%	Net Income: -49545000 Open source Revenue: 2625000 Open source
20092009-12-31	Free cash flow margin	1,432.3%	Revenue: 2006000 Open source Operating Cash Flow: 29187000 Open source Capital Expenditure: 456000 Open source
20102010-12-31	Free cash flow margin	-6,225.6%	Revenue: 688000 Open source Operating Cash Flow: -42417000 Open source Capital Expenditure: 415000 Open source
20112011-12-31	Free cash flow margin	-1,722.7%	Revenue: 2625000 Open source Operating Cash Flow: -45108000 Open source Capital Expenditure: 114000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

Unit12 -45.1M 2011

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(Unit12)	Source evidence
20092009-12-31	Operating cash flow	29187000	Operating Cash Flow: 29187000 Open source
20102010-12-31	Operating cash flow	-42417000	Operating Cash Flow: -42417000 Open source
20112011-12-31	Operating cash flow	-45108000	Operating Cash Flow: -45108000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Unit12 -45.2M 2011

Values and sources

Free cash flow values and source evidence
Period	Series	Value(Unit12)	Source evidence
20092009-12-31	Free cash flow	28731000	Operating Cash Flow: 29187000 Open source Capital Expenditure: 456000 Open source
20102010-12-31	Free cash flow	-42832000	Operating Cash Flow: -42417000 Open source Capital Expenditure: 415000 Open source
20112011-12-31	Free cash flow	-45222000	Operating Cash Flow: -45108000 Open source Capital Expenditure: 114000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2009-12-31	Liabilities / assets	Not reported	No source recorded
2010-12-31	Liabilities / assets	Not reported	No source recorded
2011-12-31	Liabilities / assets	Not reported	No source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2009-12-31	Current assets / current liabilities	Not reported	No source recorded
2010-12-31	Current assets / current liabilities	Not reported	No source recorded
2011-12-31	Current assets / current liabilities	Not reported	No source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2009 2009-01-01 – 2009-12-31	−Unit12 21.87 million Exact value Exact value: -21867000 Unit12 2009-01-01 – 2009-12-31: -21867000 Unit12 Inspect Net Income Open source Share or cite Citation for Net Income · NeurogesX Inc · 2009-12-31 NeurogesX Inc (edgar:1385830) Net Income: -21867000 Unit12 Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T19:55:01Z Snapshot: ae364e0c8dcadb5fc06f95a6b6dfdb69f3e4fa2afa8144eee986a6ffeb2adc4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385830/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=Unit12&dimensions= Input fundies:NetIncome: -21867000 Unit12 (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385830/000119312512137708/ngsx-20111231.xml#232652 Filing: 000119312512137708 The citation records this snapshot. The page link may show a newer release later.	Unit12 29.19 million Exact value Exact value: 29187000 Unit12 2009-01-01 – 2009-12-31: 29187000 Unit12 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NeurogesX Inc · 2009-12-31 NeurogesX Inc (edgar:1385830) Operating Cash Flow: 29187000 Unit12 Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T19:55:01Z Snapshot: ae364e0c8dcadb5fc06f95a6b6dfdb69f3e4fa2afa8144eee986a6ffeb2adc4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385830/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=Unit12&dimensions= Input fundies:OperatingCashFlow: 29187000 Unit12 (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385830/000119312512137708/ngsx-20111231.xml#232074 Filing: 000119312512137708 The citation records this snapshot. The page link may show a newer release later.	Unit12 456,000 Exact value Exact value: 456000 Unit12 2009-01-01 – 2009-12-31: 456000 Unit12 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NeurogesX Inc · 2009-12-31 NeurogesX Inc (edgar:1385830) Capital Expenditure: 456000 Unit12 Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T19:55:01Z Snapshot: ae364e0c8dcadb5fc06f95a6b6dfdb69f3e4fa2afa8144eee986a6ffeb2adc4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385830/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=Unit12&dimensions= Input fundies:CapitalExpenditure: 456000 Unit12 (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385830/000119312512137708/ngsx-20111231.xml#252449 Filing: 000119312512137708 The citation records this snapshot. The page link may show a newer release later.	Unit12 28.73 million Calculation and evidence 29187000 − 456000 Unit12 Exact free cash flow: 28731000 Unit12 2009-01-01 – 2009-12-31: 29187000 Unit12 · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 456000 Unit12 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NeurogesX Inc · 2009-12-31 NeurogesX Inc (edgar:1385830) Free cash flow: 28731000 Unit12 Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T19:55:01Z Snapshot: ae364e0c8dcadb5fc06f95a6b6dfdb69f3e4fa2afa8144eee986a6ffeb2adc4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385830?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 29187000 Unit12 (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385830/000119312512137708/ngsx-20111231.xml#232074 Filing: 000119312512137708 Input fundies:CapitalExpenditure: 456000 Unit12 (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385830/000119312512137708/ngsx-20111231.xml#252449 Filing: 000119312512137708 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−Unit12 44.52 million Exact value Exact value: -44516000 Unit12 2010-01-01 – 2010-12-31: -44516000 Unit12 Inspect Net Income Open source Share or cite Citation for Net Income · NeurogesX Inc · 2010-12-31 NeurogesX Inc (edgar:1385830) Net Income: -44516000 Unit12 Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T19:55:01Z Snapshot: ae364e0c8dcadb5fc06f95a6b6dfdb69f3e4fa2afa8144eee986a6ffeb2adc4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385830/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=Unit12&dimensions= Input fundies:NetIncome: -44516000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385830/000119312512137708/ngsx-20111231.xml#232991 Filing: 000119312512137708 The citation records this snapshot. The page link may show a newer release later.	−Unit12 42.42 million Exact value Exact value: -42417000 Unit12 2010-01-01 – 2010-12-31: -42417000 Unit12 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NeurogesX Inc · 2010-12-31 NeurogesX Inc (edgar:1385830) Operating Cash Flow: -42417000 Unit12 Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T19:55:01Z Snapshot: ae364e0c8dcadb5fc06f95a6b6dfdb69f3e4fa2afa8144eee986a6ffeb2adc4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385830/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=Unit12&dimensions= Input fundies:OperatingCashFlow: -42417000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385830/000119312512137708/ngsx-20111231.xml#232266 Filing: 000119312512137708 The citation records this snapshot. The page link may show a newer release later.	Unit12 415,000 Exact value Exact value: 415000 Unit12 2010-01-01 – 2010-12-31: 415000 Unit12 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NeurogesX Inc · 2010-12-31 NeurogesX Inc (edgar:1385830) Capital Expenditure: 415000 Unit12 Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T19:55:01Z Snapshot: ae364e0c8dcadb5fc06f95a6b6dfdb69f3e4fa2afa8144eee986a6ffeb2adc4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385830/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=Unit12&dimensions= Input fundies:CapitalExpenditure: 415000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385830/000119312512137708/ngsx-20111231.xml#252639 Filing: 000119312512137708 The citation records this snapshot. The page link may show a newer release later.	−Unit12 42.83 million Calculation and evidence -42417000 − 415000 Unit12 Exact free cash flow: -42832000 Unit12 2010-01-01 – 2010-12-31: -42417000 Unit12 · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 415000 Unit12 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NeurogesX Inc · 2010-12-31 NeurogesX Inc (edgar:1385830) Free cash flow: -42832000 Unit12 Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T19:55:01Z Snapshot: ae364e0c8dcadb5fc06f95a6b6dfdb69f3e4fa2afa8144eee986a6ffeb2adc4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385830?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -42417000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385830/000119312512137708/ngsx-20111231.xml#232266 Filing: 000119312512137708 Input fundies:CapitalExpenditure: 415000 Unit12 (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385830/000119312512137708/ngsx-20111231.xml#252639 Filing: 000119312512137708 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−Unit12 49.55 million Exact value Exact value: -49545000 Unit12 2011-01-01 – 2011-12-31: -49545000 Unit12 Inspect Net Income Open source Share or cite Citation for Net Income · NeurogesX Inc · 2011-12-31 NeurogesX Inc (edgar:1385830) Net Income: -49545000 Unit12 Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T19:55:01Z Snapshot: ae364e0c8dcadb5fc06f95a6b6dfdb69f3e4fa2afa8144eee986a6ffeb2adc4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385830/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=Unit12&dimensions= Input fundies:NetIncome: -49545000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385830/000119312512137708/ngsx-20111231.xml#233330 Filing: 000119312512137708 The citation records this snapshot. The page link may show a newer release later.	−Unit12 45.11 million Exact value Exact value: -45108000 Unit12 2011-01-01 – 2011-12-31: -45108000 Unit12 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NeurogesX Inc · 2011-12-31 NeurogesX Inc (edgar:1385830) Operating Cash Flow: -45108000 Unit12 Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T19:55:01Z Snapshot: ae364e0c8dcadb5fc06f95a6b6dfdb69f3e4fa2afa8144eee986a6ffeb2adc4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385830/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=Unit12&dimensions= Input fundies:OperatingCashFlow: -45108000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385830/000119312512137708/ngsx-20111231.xml#232459 Filing: 000119312512137708 The citation records this snapshot. The page link may show a newer release later.	Unit12 114,000 Exact value Exact value: 114000 Unit12 2011-01-01 – 2011-12-31: 114000 Unit12 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NeurogesX Inc · 2011-12-31 NeurogesX Inc (edgar:1385830) Capital Expenditure: 114000 Unit12 Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T19:55:01Z Snapshot: ae364e0c8dcadb5fc06f95a6b6dfdb69f3e4fa2afa8144eee986a6ffeb2adc4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385830/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=Unit12&dimensions= Input fundies:CapitalExpenditure: 114000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385830/000119312512137708/ngsx-20111231.xml#252829 Filing: 000119312512137708 The citation records this snapshot. The page link may show a newer release later.	−Unit12 45.22 million Calculation and evidence -45108000 − 114000 Unit12 Exact free cash flow: -45222000 Unit12 2011-01-01 – 2011-12-31: -45108000 Unit12 · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 114000 Unit12 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NeurogesX Inc · 2011-12-31 NeurogesX Inc (edgar:1385830) Free cash flow: -45222000 Unit12 Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T19:55:01Z Snapshot: ae364e0c8dcadb5fc06f95a6b6dfdb69f3e4fa2afa8144eee986a6ffeb2adc4d Dimensions: Consolidated View: https://fundies.io/companies/edgar/1385830?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -45108000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385830/000119312512137708/ngsx-20111231.xml#232459 Filing: 000119312512137708 Input fundies:CapitalExpenditure: 114000 Unit12 (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1385830/000119312512137708/ngsx-20111231.xml#252829 Filing: 000119312512137708 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

28 filings · 700 latest values · 700 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001385830, 1385830, edgar:1385830

Also known as NeurogesX Inc

NeurogesX Inc

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2011 2011-01-01 – 2011-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation